Back to Search
DOUGLAS MAYERS, M.D,
M.D,
Anesthesiology Physician
NPI: 1508820135IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
35042344M(OH)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1977
Research & Publications (20)
Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi.
PMID 19397436·AIDS Educ Prev·2009
8-other
Population pharmacokinetics of telbivudine and determination of dose adjustment for patients with renal impairment.
PMID 19395586·J Clin Pharmacol·2009
8-other
Single-dose escalation and multiple-dose safety, tolerability, and pharmacokinetics of IDX899, a candidate human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitor, in healthy subjects.
PMID 19223643·Antimicrob Agents Chemother·2009
2-rct
HIV-1 drug resistance in variants from the female genital tract and plasma.
PMID 17230413·J Infect Dis·2007
8-other
Long-term efficacy and safety of tipranavir boosted with ritonavir in HIV-1-infected patients failing multiple protease inhibitor regimens: 80-week data from a phase 2 study.
PMID 17554217·J Acquir Immune Defic Syndr·2007
3-trial
Antiviral activity of low-dose alovudine in antiretroviral-experienced patients: results from a 4-week randomized, double-blind, placebo-controlled dose-ranging trial.
PMID 17461857·HIV Med·2007
2-rct
Efficacy and safety of three doses of tipranavir boosted with ritonavir in treatment-experienced HIV type-1 infected patients.
PMID 17263650·AIDS Res Hum Retroviruses·2007
4-observational
Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir.
PMID 16928764·J Virol·2006
3-trial
Seeking ethical designs for HIV clinical trials in treatment-experienced patients: an industry perspective.
PMID 17147497·AIDS Res Hum Retroviruses·2006
8-other
Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-week results of the RESIST-2 trial.
PMID 17051504·Clin Infect Dis·2006
3-trial
Efficacy of the protease inhibitors tipranavir plus ritonavir in treatment-experienced patients: 24-week analysis from the RESIST-1 trial.
PMID 17051503·Clin Infect Dis·2006
3-trial
Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 study.
PMID 16951642·J Acquir Immune Defic Syndr·2006
4-observational
Practical guidelines to interpret plasma concentrations of antiretroviral drugs.
PMID 15828857·Clin Pharmacokinet·2005
8-other
A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients.
PMID 15097154·J Acquir Immune Defic Syndr·2004
3-trial
A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients.
PMID 14562855·J Acquir Immune Defic Syndr·2003
8-other
Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus.
PMID 12944569·N Engl J Med·2003
3-trial
Genetic diversity and response to IFN of the NS3 protease gene from clinical strains of the hepatitis C virus.
PMID 12111414·Arch Virol·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9500 EUCLID AVE
CLEVELAND, OH 44195 - Phone
- (800) 223-2273
Quick Facts
- NPI
- 1508820135
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 49
- Publications
- 20
Are you this provider?
Claim Your Profile